Directorate Change
19 August 2010 - 9:00PM
UK Regulatory
TIDMAHI
RNS Number : 3027R
Allied Healthcare International Inc
19 August 2010
Allied Healthcare International Inc. Announces Changes to Its Board of Directors
NEW YORK, NY--(Marketwire - August 19, 2010) - Allied Healthcare International
Inc. (NASDAQ: AHCI) (AIM: AHI), a leading provider of flexible healthcare
staffing services in the United Kingdom, announced today that G. Richard Green
has tendered his resignation as a member of the Company's Board of Directors for
personal reasons, effective August 21, 2010. Mr. Green has been a director of
Allied since 1998 and recently served on the Nominating and Corporate Governance
Committee of the Board.
The Company also announced that Professor Raymond John Playford has been
appointed to the Board of Directors of Allied, effective August 21, 2010. Prof.
Playford, age 50, has served as Medical Advisor to the Board of Allied since
June 2010.
Dr. Jeffrey S. Peris, Chairman of the Board of Allied Healthcare International
Inc., commented, "Richard has served with distinction on our Board. His
intellect, depth of business knowledge and leadership experience have
contributed greatly to Allied's growth and success throughout his long tenure as
our director. On behalf of the entire Board, senior management team and
employees of Allied, we want to wish Richard years of health and happiness."
Dr. Peris also stated, "Ray has already made many valuable contributions since
he joined us as Medical Advisor, and we welcome him to the Board to further
assist us in augmenting the growth strategies of our Company. His wealth of
clinical, healthcare and NHS expertise will both support our commitment to
providing our customers with one of the highest levels of quality care in our
industry and to enhancing the market leadership of Allied."
Prof. Playford has more than 25 years of experience in the medical field,
specializing in clinical research. He is currently Deputy Warden and Professor
of Medicine at Barts and the London School of Medicine and Dentistry, as well as
Vice Principal (NHS Liaison), Queen Mary, University of London. Prof. Playford
is also a Non-Executive Director of Barking, Havering and Redbridge NHS Trust
and a director of Repair and Protection Foods Ltd., which is engaged in food
research. He has also been an advisor to both the UK Government and the
healthcare industry.
Prof. Playford received a Medical degree (M.B., B.S.) in 1978 from St.
Bartholomew's Medical School and his PhD in 1992 from the Royal Postgraduate
Medical School at Imperial College, London. He is a Fellow of the Royal College
of Physicians (UK) and the Royal College of Pathologists (UK) and was Visiting
Professor, Harvard Medical School and Massachusetts General Hospital in 2002. He
has published over 100 original scientific and clinical papers and received
several awards for research including the British Society of Gastroenterology
(BSG) Sir Francis Avery Jones Research Medal in 1995 and Canadian Alberta
Heritage Foundation for Medical Research in 2004. He was made a Fellow of the
Academy of Medical Scientists in 2002 and, as a result of his contribution to
public education on health matters, became a Fellow of the Royal Society of Arts
in 2000.
There are no further disclosures regarding Prof. Playford that are required to
be set forth in this press release under the AIM rules.
About Allied Healthcare International Inc.
Allied Healthcare International Inc. is a leading provider of flexible
healthcare staffing services in the United Kingdom. Allied operates a
community-based network of approximately 115 branches with the capacity to
provide carers (known as home health aides in the U.S.), nurses, and specialized
medical personnel to locations covering approximately 90% of the U.K.
population. Allied meets the needs of private patients, community care, nursing
and care homes, and hospitals. For more news and information please visit:
www.alliedhealthcare.com.
Forward-Looking Statements
Certain statements contained in this news release may be forward-looking
statements. These forward-looking statements are based on current expectations
and projections about future events. Actual results could differ materially from
those discussed in, or implied by, these forward-looking statements. Factors
that could cause actual results to differ from those implied by the
forward-looking statements include: general economic and market conditions; the
effect of the change in the U.K. government and the impact of proposed changes
in recent policy making related to health and social care that may reduce
revenue and profitability; Allied's ability to continue to recruit and retain
flexible healthcare staff; Allied's ability to enter into contracts with local
government social services departments, NHS Trusts, hospitals, other healthcare
facility clients and private clients on terms attractive to Allied; the general
level of demand for healthcare and social care; dependence on the proper
functioning of Allied's information systems; the effect of existing or future
government regulation of the healthcare and social care industry, and Allied's
ability to comply with these regulations; the impact of medical malpractice and
other claims asserted against Allied; the effect of regulatory change that may
apply to Allied and that may increase costs and reduce revenues and
profitability; Allied's ability to use net operating loss carry forwards to
offset net income; the effect that fluctuations in foreign currency exchange
rates may have on our dollar-denominated results of operations; and the
impairment of goodwill, of which Allied has a substantial amount on the balance
sheet, may have the effect of decreasing earnings or increasing losses. Other
factors that could cause actual results to differ from those implied by the
forward-looking statements in this press release include those described in
Allied's most recently filed SEC documents, such as its most recent annual
report on Form 10-K, all quarterly reports on Form 10-Q and any current reports
on Form 8-K filed since the date of the last Form 10-K. Allied undertakes no
obligation to publicly update or revise any forward-looking statements, whether
as a result of new information, future events, or otherwise.
CONTACT
Allied Healthcare International Inc.
Sandy Young
Chief
Executive Officer
Paul Weston
Chief Financial Officer
+44 (0) 17
8581 0600
Or
Piper Jaffray Ltd. (Nominated Adviser)
Matthew
Flower
Rupert Winckler
+44 (0) 20 3142 8700
Or
ICR
Inc.
Sherry Bertner
Managing Director
+1 646 277
1200
Sherry.Bertner@icrinc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAFVLLFBVFXBBD
Allied Healthcare (LSE:AHI)
Historical Stock Chart
From Oct 2024 to Nov 2024
Allied Healthcare (LSE:AHI)
Historical Stock Chart
From Nov 2023 to Nov 2024